FIELD: medicine. SUBSTANCE: method involves injecting solution possessing high fibrinolytic and antibacterial activity into the abdominal cavity. The solution has components, in % by mass: pepsin 5.0-5.5, ascorbic acid 4.5-5.0, glucose 23.0-25.0, trimecain 0.75-1.0, the rest is water. EFFECT: prevented commissures formation.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CREATING LAPAROSTOMA IN EXTENSIVE PURULENT PERITONITIS | 2010 |
|
RU2466682C2 |
| DIAGNOSTIC TECHNIQUE OF ACUTE PERITONITIS PHASES | 2008 |
|
RU2362481C1 |
| METHOD FOR TREATING ABDOMINAL CAVITY IN THE CASES OF PERITONITIS | 2000 |
|
RU2207887C2 |
| METHOD FOR SELECTING THE SURGICAL TREATMENT TACTICS FOR DIFFERENT APPENDICULAR PERITONITIS | 2021 |
|
RU2770281C1 |
| METHOD FOR CHOOSING SURGICAL APPROACH IN PERITONITIS ON BASIS OF DIAGNOSTIC VIDEOLAPAROSCOPY | 2011 |
|
RU2465810C1 |
| METHOD FOR TREATING EXTENSIVE PURULENT PERITONITIS | 2005 |
|
RU2306927C1 |
| METHOD FOR PREOPERATIVE PREPARATION OF PATIENTS SUFFERING EXTENSIVE PERITONITIS | 2010 |
|
RU2460552C2 |
| METHOD OF SURGICAL TREATMENT OF PERITONITIS IN CHILDREN | 1997 |
|
RU2145807C1 |
| METHOD FOR PREVENTION OF POSTOPERATIVE ENTEROPARESIS | 2009 |
|
RU2445130C2 |
| METHOD OF TREATING ABDOMINAL CAVITY IN PATIENTS WITH PERITONITIS | 2005 |
|
RU2281123C1 |
